Hepatic Oncology is a peer-reviewed english-language open-access journal published by Taylor & Francis in United Kingdom, operating under an open-access model since 2018. The journal covers Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology and Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Hepatic Oncology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
To date, Hepatic Oncology has published 205 articles. Articles are minted with DOIs through the prefix 10.2217. All submissions undergo plagiarism screening before peer review.
Keywords
hepatic oncology, liver cancer, liver tumours
At a glance
- Publisher
- Taylor & Francis
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Double anonymous peer review
- OA since
- 2018
- Review time
- 13 weeks
- DOI prefix
10.2217- Plagiarism check
- Yes
ISSN
- 2045-0923
- electronic
- 2045-0931
Frequently asked questions
Is Hepatic Oncology peer-reviewed?
Does Hepatic Oncology charge an article processing charge (APC)?
What subjects does Hepatic Oncology publish?
What languages does Hepatic Oncology accept?
What is the ISSN of Hepatic Oncology?
2045-0923 (print) · 2045-0931 (electronic).